NanoViricides, Inc. (NNVC.PK) Appoints Project Manager and Engineering Firm for FDA cGMP Plant; Provides Update on Anti-Influenza Program  
12/10/2012 10:09:44 AM

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that it has retained the services of Mr. Phil Mader and his firm, MPH Engineering, LLC (“MPH”), to help with the overall project management and design engineering of its laboratory and cGMP pilot production facility. This facility will be built by renovating an existing 18,000 sq. ft. light manufacturing plant on a 4.2 acre lot in Shelton, CT, as previously announced. MPH will provide overall engineering and project management services for the whole facility that includes the cGMP facility, laboratories, and office spaces, and will be responsible for overall project management of the detailed design and construction phases. The cGMP area itself will be designed by a separate firm, while MPH will be responsible for successful implementation of the entire project in collaboration with the firm that will provide the cGMP area.